Dave Sebastian

Dave Sebastian

Contemporary Amperex Technology Co. Ltd. is guiding to price its Hong Kong share sale at the top end it had earlier indicated, according to people familiar with the matter, thanks to strong demand for the stock.

Jiangsu Hengrui Pharmaceuticals Co. has started taking investor orders for a Hong Kong listing that could raise as much as HK$9.9 billion ($1.3 billion), the latest significant deal to boost the financial hub’s share-sale recovery.

South Korea’s LG Chem Ltd. is seeking to raise $1 billion in bonds that can be exchanged for shares in LG Energy Solution Ltd. to refinance another issuance.

The stock market’s striking rebound from the tariff disruption imposed by US President Donald Trump has rekindled global IPO activity, as businesses without direct exposure to trade look to get deals done before the summer — and before geopolitical tensions flare up again.

A Pentagon blacklisting, US congressional scrutiny and a global trade war haven’t been enough to stop the world’s largest maker of electric-car batteries from completing the globe’s biggest share sale so far this year.

Contemporary Amperex Technology Co. Ltd. has raised HK$41 billion ($5.2 billion) for its Hong Kong share sale after arrangers of the deal exercised the so-called greenshoe option to increase the offering, making the world’s biggest listing this year even bigger.

Jiangsu Hengrui Pharmaceuticals Co. priced its Hong Kong stock offering at the top of the marketed range to raise HK$9.9 billion ($1.3 billion).

Chinese companies are seizing on a window of opportunity to raise capital as global investors pour money into Asian assets in search of alternatives to the US.

JPMorgan Chase & Co. underwrote Contemporary Amperex Technology Co. Ltd.’s Hong Kong listing despite opposition from US lawmakers, given that Washington hasn’t placed sanctions on the Chinese battery maker, Chief Executive Officer Jamie Dimon said.